Literature DB >> 14730407

Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with (68)Ga-DOTATOC PET.

Marcus Henze1, Jochen Schuhmacher, Antonia Dimitrakopoulou-Strauss, Ludwig G Strauss, Helmut R Mäcke, Michael Eisenhut, Uwe Haberkorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14730407     DOI： 10.1007/s00259-003-1436-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  3 in total

1.  PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas.

Authors:  M Henze; J Schuhmacher; P Hipp; J Kowalski; D W Becker; J Doll; H R Mäcke; M Hofmann; J Debus; U Haberkorn
Journal:  J Nucl Med       Date:  2001-07       Impact factor: 10.057

2.  Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data.

Authors:  M Hofmann; H Maecke; R Börner; E Weckesser; P Schöffski; L Oei; J Schumacher; M Henze; A Heppeler; J Meyer; H Knapp
Journal:  Eur J Nucl Med       Date:  2001-10-31

3.  Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.

Authors:  Jörg Kowalski; Marcus Henze; Jochen Schuhmacher; Helmut R Mäcke; Michael Hofmann; Uwe Haberkorn
Journal:  Mol Imaging Biol       Date:  2003 Jan-Feb       Impact factor: 3.488
  3 in total
  5 in total

1.  Imaging of gastroenteropancreatic neuroendocrine tumors.

Authors:  Eik Hock Tan; Cher Heng Tan
Journal:  World J Clin Oncol       Date:  2011-01-10

2.  68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer.

Authors:  Sangeeta Ray Banerjee; Mrudula Pullambhatla; Youngjoo Byun; Sridhar Nimmagadda; Gilbert Green; James J Fox; Andrew Horti; Ronnie C Mease; Martin G Pomper
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

3.  Synthesis and biodistribution of lipophilic and monocationic gallium radiopharmaceuticals derived from N,N'-bis(3-aminopropyl)-N,N'-dimethylethylenediamine: potential agents for PET myocardial imaging with 68Ga.

Authors:  Yui-May Hsiao; Carla J Mathias; Shiaw-Pyng Wey; Phillip E Fanwick; Mark A Green
Journal:  Nucl Med Biol       Date:  2009-01       Impact factor: 2.408

Review 4.  Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency.

Authors:  Shuang Liu
Journal:  Bioconjug Chem       Date:  2009-12       Impact factor: 4.774

5.  Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

Authors:  P Antunes; M Ginj; H Zhang; B Waser; R P Baum; J C Reubi; H Maecke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-16       Impact factor: 10.057
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.